A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized treatment.

Activation of the androgen receptor (AR) despite androgen ablation and anti-androgen therapy seems to play a pivotal role in hormone-refractory progression of prostate cancer. The above postulation is ...

Molecular biomarkers can serve as useful diagnostic markers, as prognostic markers for predicting clinical behavior, or as targets for new therapeutic strategies. Application of expression microarray ...

The University Hospitals Urology Institute is the first health care facility in Northeast Ohio to use a new technique to diagnose prostate cancer, officials recently announced. According to UH, the ...

Earlier this week, researchers presented data from the OPTIMUM (Optimization of Prostate Biopsy – Micro-Ultrasound Versus MRI) trial at the European Association of Urology Congress in Madrid, Spain.

Technology to perform prostate biopsies has been relatively unchanged since the 1980's. Traditional techniques only sample the lower portion of the prostate, yet nearly 30 percent of cancers are ...

Scientists at the Karolinska Institute in Sweden recently reported that magnetic resonance imaging (MRI) could reduce overdiagnosis and thereby improve prostate cancer screening. Now, the same team ...

A University of Illinois and Mayo collaboration has demonstrated a novel gene expression analysis technique that can accurately measure levels of RNA quickly and directly from a cancerous tissue ...

A new, pioneering procedure was used to treat a record number of prostate patients in a day. Frimley Health NHS Foundation trust were able to break their record thanks to the use of a robot-assisted ...